Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 112

Proxymity pulls in $20.5m

Citi-founded shareholder communication portal creator Proxymity has raised an initial $20.5m sum to expand its software and target additional markets.

May 6, 2020

Medable mediates $25m

PPD has backed clinical trial preparation software developer Medable as an existing investor having also partnered the business to launch a telemedicine-based clinical trial product last year.

May 6, 2020

Near Protocol collates fresh funding

The blockchain software deployment service has raised $21.6m to follow a series A round last year that included contributions from Coinbase Ventures, Ideo Colab Ventures and Ripple's Xpring.

May 6, 2020

Zeitgold treasures series B funding

Deutsche Bank and Axa Innovation Campus featured in a $29.2m round that brought enterprise book-keeping app developer Zeitgold's funding haul to approximately $57m.

May 5, 2020

ZAF Energy stores $22m

ZAF Energy Systems has raised $45.6m to date after a series A round that featured the corporate venture capital arm of Holt Cat.

May 5, 2020

Vida Health inspires $25m commitment

Workday Ventures returned for a $25m funding round for the online healthcare portal, whose shareholders also include GuideWell Mutual and Teladoc.

May 4, 2020

InsideBoard inserts series B funding

Axa Venture Partners and Orange Digital Ventures backed a $27.2m round that will fund product development and international growth for the employee engagement software provider.

May 1, 2020

Salesforce slots into Niche for $35m series C

Salesforce Ventures has thrown its weight behind Niche as the educational matchmaking service prepares to add thousands of schools to its platform.

Apr 30, 2020

Taysha stakes out $30m seed round

UT Southwestern has formed central nervous system diseases treatment developer Taysha Gene Therapies with executives who previously worked for OSU's Avexis.

Apr 30, 2020

Actym Therapeutics actions $34m

Boehringer Ingelheim Venture Fund co-led a series A round set to drive clinical work on UC Berkeley-founded Actym Therapeutics' immunotherapy pipeline.

Apr 29, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here